Clinicopathologic Analysis of the Impact of CD23 Expression in Plasma Cell Myeloma with t(11;14)(q13;q32)

被引：0
|
作者：
Buonaccorsi, J. N. [1 ]
Kroft, S. H. [1 ]
Harrington, A. [1 ]
Van Tuinen, P. [1 ]
Olteanu, H. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1225
引用
收藏
页码：288A / 288A
页数：1
相关论文
共 50 条
  • [31] The (11;14)(q13;q32) translocation in multiple myeloma (MM): A morphologic and immunohistochemical study
    Hoyer, JD
    Fonseca, R
    Greipp, PR
    Hanson, CA
    Kurtin, PJ
    LABORATORY INVESTIGATION, 1999, 79 (01) : 139A - 139A
  • [32] Correlation Between Losses of IGH or Its Segments and Deletions of 13q14 in t(11;14)(q13;q32) Multiple Myeloma
    Trakhtenbrot, Luba
    Hardan, Izhar
    Koren-Michowitz, Maya
    Oren, Shirley
    Yshoev, Galina
    Rechavi, Gideon
    Nagler, Arnon
    Amariglio, Ninette
    GENES CHROMOSOMES & CANCER, 2010, 49 (01): : 17 - 27
  • [33] Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas
    Siebert, R
    Matthiesen, P
    Harder, S
    Zhang, Y
    Borowski, A
    Zuhlke-Jenisch, R
    Plendl, H
    Metzke, S
    Joos, S
    Zucca, E
    Weber-Matthiesen, K
    Roggero, E
    Grote, W
    Schlegelberger, B
    ANNALS OF ONCOLOGY, 1998, 9 (05) : 519 - 526
  • [34] Expression of cyclin D1 and its relation with t(11;14)(q13;q32) and trisomy 11 in multiple myeloma patients
    Akanksha, A. Kalal
    Sucheta, Kumari
    Rajesh, Krishna
    Shubha, P. Bhat
    Prashanth, Shetty
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2022, 17 (11): : 29 - 36
  • [35] Myeloma (MM) and the t(11;14)(q13;q32); Increasing evidence for a biologically distinct subset of patients.
    Fonseca, R
    Harrington, D
    Oken, MM
    Hoyer, JD
    Dewald, GW
    Bailey, RJ
    Van Wier, SA
    Henderson, KJ
    Kay, NE
    van Ness, B
    Blood, EA
    Greipp, PR
    BLOOD, 2000, 96 (11) : 151A - 151A
  • [36] Cytogenetics in multiple myeloma:: A multicenter study of 24 patients with t(11;14)(q13;q32) or its variant
    Laï, JL
    Michaux, L
    Dastugue, N
    Vasseur, F
    Daudignon, A
    Facon, T
    Bauters, F
    Zandecki, M
    CANCER GENETICS AND CYTOGENETICS, 1998, 104 (02) : 133 - 138
  • [37] Cytogenetics in multiple myeloma: A multicentre study of 24 patients with t(11;14) (q13;q32) or variant.
    Lai, JL
    Michaux, L
    Dastugue, N
    Daudignon, A
    Vasseur, F
    Zandecki, M
    Bauters, F
    Facon, T
    BLOOD, 1996, 88 (10) : 1542 - 1542
  • [38] CLINICOPATHOLOGIC CHARACTERISTICS OF THE T(14;19)(Q32;Q13)-POSITIV SPLENIC MARGINAL ZONE LYMPHOMA
    Julhakyan, H.
    Obukhova, T.
    Kremenetskaya, A.
    Zvonkov, E.
    Kaplanskaya, I.
    Vorobiev, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 651 - 651
  • [39] Cytogenetic Study and Analysis of Protein Expression in Plasma Cell Myeloma with t(11;14)(q13;q32): Absence of BCL6 and SOX11, and Infrequent Expression of CD20 and PAX5
    Yokoi, Satoshi
    Sakai, Hirotaka
    Uchida, Akiko
    Uemura, Yu
    Sato, Kazuyuki
    Tsuruoka, Yuka
    Nishio, Yuji
    Matsunawa, Manabu
    Suzuki, Yoshinori
    Isobe, Yasushi
    Kato, Masayuki
    Inoue, Yasuyuki
    Hoshikawa, Masahiro
    Miura, Ikuo
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2015, 55 (03) : 137 - 143
  • [40] TPA stimulation culture for improved detection of t(11;14)(q13;q32) in mantle cell lymphoma
    Barouk-Simonet, E
    Andrieux, J
    Copin, MC
    Grardel-Duflos, N
    Huyghe, P
    Patte, JH
    Preudhomme, C
    Quesnel, B
    Laï, JL
    ANNALES DE GENETIQUE, 2002, 45 (03): : 165 - 168
12345